Medicinal cannabis manufacturer Little Green Pharma (LGP) has tabled a 427 per cent increase in revenue in its half-year report
The healthcare stock ended December with $3.77 million in revenue, up from just $716,000 in revenue at the end of 1H FY20
An additional 150 GPs signed up with Little Green over the period, while 4900 new patients subscribed to its products
LGP's sales also grew substantially year on year, with over 21,000 units sold, representing an increase of 340 per cent Little Green ended the half-year with a maiden profit, a strong turnaround from the previous year's $5.5 million loss
It also had $4.45 million in the bank and has since raised an additional $22.1 million in capital via a placement
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)